Paclitaxel protein-bound particles
NDC 69097-398, Paclitaxel protein-bound particles, injection, powder, lyophilized, for suspension, from Cipla USA Inc..
- Product NDC
- 69097-398
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209657
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-398 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PACLITAXEL100 mg/20mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-398-78 | 69097039878 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-398-78) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/15eba86c-d9de-42e6-bc95-70ba4c015e72Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69097-398
Use it
Look up 69097-398 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-398 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-398. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.